Anticoccidial Drugs Market by Type and Geography - Forecast and Analysis 2022-2026

The anticoccidial drugs market share is expected to increase to USD 76.95 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 4.1%.

This anticoccidial drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers anticoccidial drug market segmentation by type (ionophore anticoccidial and chemical derivative anticoccidial) and geography (North America, Europe, Asia, and Rest of World (ROW)). The anticoccidial drugs market report also offers information on several market vendors, including Bayer AG, Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Huvepharma EOOD, Impextraco NV, Kemin Industries Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Novartis AG, Phibro Animal Health Corp., Qilu Animal Health Products Co., Ltd., Vetoquinol SA, VH Group, Virbac, and Zoetis Inc. among others.

What will the Anticoccidial Drugs Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Anticoccidial Drugs Market Size for the Forecast Period and Other Important Statistics

 

Anticoccidial Drugs Market: Key Drivers, Trends, and Challenges

The growing demand for feed additives owing to rising disease outbreaks in livestock is notably driving the anticoccidial drugs market growth, although factors such as stringent government regulations may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the anticoccidial drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Anticoccidial Drugs Market Driver

The growing demand for feed additives owing to rising disease outbreaks in livestock is one of the key drivers fueling the anticoccidial drugs market growth. Disease outbreaks affect animal health and lead to the loss of livestock. They also disrupt livestock product trade and inhibit sustained investments in livestock production. The use of feed additives, such as anticoccidial drugs, prevents coccidiosis in poultry and other animals and improves the overall feed absorption and assimilation. This apparent benefit and its increasing awareness and acceptance among livestock producers are expected to drive the global anticoccidial market during the forecast period.

Key Anticoccidial Drugs Market Trend

Advances in biotechnology is one of the key anticoccidial drugs market trends propelling the market growth. Primarily, genomic analysis of all seven Eimeria species that cause coccidiosis in poultry has been accomplished, which may lead to the identification and validation of species-specific protein targets. Moreover, new research on Eimeria species is helping vendors to launch new anticoccidial drugs. For instance, in March 2021, Elanco Animal Health Inc. launched two new veterinary products in Sri Lanka via the local agent Baur and Co. The two products are anticoccidial feed additives. Such new drug discoveries will propel market growth during the forecast period.

Key Anticoccidial Drugs Market Challenge

Stringent government regulations is one of the key factors limiting the anticoccidial drug market growth. There are some restrictions imposed on the use of veterinary drugs or feed additives, which compel manufacturers to follow regulations. For instance, In 2017, the US restricted the use of medically important antibiotics in feed to VFD that require veterinary oversight. The use of a VFD drug in feed is permitted only under the professional supervision of a licensed veterinarian. All agricultural and veterinary chemical products sold in Australia must be registered by the Australian Pesticides and Veterinary Medicines Authority (APVMA). Therefore, such imposed stringent regulations may limit the market growth during the forecast period.

This anticoccidial drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global anticoccidial drugs market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the anticoccidial drugs market during the forecast period.

Who are the Major Anticoccidial Drugs Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

• Bayer AG
• Bioproperties Pty Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Cronus Pharma
• Elanco Animal Health Inc.
• Huvepharma EOOD
• Impextraco NV
• Kemin Industries Inc.
• LABORATORIOS HIPRA SA
• Merck and Co. Inc.
• Novartis AG
• Phibro Animal Health Corp.
• Qilu Animal Health Products Co., Ltd.
• Vetoquinol SA
• VH Group
• Virbac
• Zoetis Inc.

 

This statistical study of the anticoccidial drugs market encompasses successful business strategies deployed by the key vendors. The anticoccidial drugs market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

• Bayer.com - The company offers Anticoccidial that includes Polyether antibiotics, Ionophores, Monovalent ionophores, and Monovalent glycosidic ionophores.
• Boehringer-ingelheim.com - The company offers Anticoccidial that includes Hatchpak cocci, which are used to aid in the prevention of coccidiosis.
• Ceva.com - The company offers Anticoccidial that includes IMMUCOX which is designed to help healthy Chicken Broilers and Roasters develop immunity to coccidiosis.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The anticoccidial drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Anticoccidial Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the anticoccidial drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Anticoccidial Drugs Market?

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market’s growth will originate from North America during the forecast period. The US is the key market for the anticoccidial drugs market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The increasing livestock in the region, rising demand for quality, and growing concerns about livestock health will facilitate the anticoccidial drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 had a negative impact on the regional market. However, the region has been gradually propelling its economic activities due to large-scale vaccination drives since 2021, which are further supporting the growth of the regional economy. This further boosts the growth of the regional livestock activities and, consequently, is expected to drive the growth of the regional market during the forecast period.

What are the Revenue-generating Type Segments in the Anticoccidial Drugs Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The anticoccidial drugs market share growth by the ionophore anticoccidial segment will be significant during the forecast period. Ionophores have been the most preferred drugs to control coccidiosis as it slowly develops resistance in animals, and they do not completely suppress parasite development, thus allowing the development of immunity in animals after the first exposure. The divalent ionophore lasalocid has been shown to de- crease oocyst production in naturally infected lambs and cattle and in a few cases improve performance and reduce clinical signs of disease when included in the fee Ionophores, also used for lamb and cattle. Such factors are expected to boost the market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the anticoccidial drugs market size and actionable market insights on post COVID-19 impact on each segment.

 

Anticoccidial Drugs Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 4.1%
Market growth 2022-2026	$ 76.95 million
Market structure	Fragmented
YoY growth (%)	3.5
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 42%
Key consumer countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Bayer AG, Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Huvepharma EOOD, Impextraco NV, Kemin Industries Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Novartis AG, Phibro Animal Health Corp., Qilu Animal Health Products Co., Ltd., Vetoquinol SA, VH Group, Virbac, and Zoetis Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Anticoccidial Drugs Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive anticoccidial drugs market growth during the next five years
• Precise estimation of the anticoccidial drugs market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the anticoccidial drugs industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of anticoccidial drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch